米非司酮联合依沙吖啶用于瘢痕子宫中期妊娠引产效果观察

    The observation of Mifepristone combined with Ethacridine used in mid-pregnancy induced labour with uterine scar

    • 摘要: 目的:探讨米非司酮联合依沙吖啶用于瘢痕子宫中期妊娠引产的可行性、临床效果和安全性。方法:将98例瘢痕子宫中期妊娠引产孕妇随机分为米非司酮联合依沙吖啶组(A组)和单用依沙吖啶组(B组),各49例。比较2组引产成功率、胎盘胎膜残留、宫颈裂伤发生情况。结果:A组均引产成功,B组有3例因先兆子宫破裂改行剖宫产术;2组引产成功率差异无统计学意义(P0.05),2组孕妇宫缩发动时宫颈成熟度、胎盘胎膜残留率、宫颈裂伤率差异均有统计学意义(P0.01),引产效果A组明显优于B组。结论:米非司酮联合依沙吖啶用于瘢痕子宫中期妊娠引产有效、安全,值得临床推广。

       

      Abstract: Objective:To investigate the feasibility,clinical effects,safety,induction of labor in mid-pregnancy patients with uterine scar treated by mifepristone combined with ethacridine.Methods:Ninety-eight mid-pregnant women with uterine scar were randomly divided into group A(mifepristone conbined with ethacridine) and group B(ethacridine only),forty-nine cases each group.Success of induced labor,placenta fetal membrane residual rate and cervical laceration rate were observed and compared.Results:Forty-nine cases in group A were all success,3 cases in group B were under cesarean section because of threatened uterine rupture,there were no significant difference in the success rate(P 0.05).Contractions started with cervical maturity,placenta fetal membrane residual rate,cervical laceration rate were significantly different(P 0.01),the effect of induced labor,group A evidently better than group B.Conclusions:Mifepristone combined with ethacridine for mid-pregnancy abortion with uterine scar is safe,convenient,effective and worthy of clinical application.

       

    /

    返回文章
    返回